Medical Weight Loss for Kokomo, Indiana Residents

Kokomo, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Kokomo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Kokomo: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Indiana address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Kokomo Residents Choose New Hope Weight Loss

A lot of clinics talk about supervision in the abstract. We can name the person doing it. Dr. Anjmun Sharma, MD oversees every Kokomo case personally, which means your dose, your check-ins, and your safety calls are decisions a single physician owns from start to finish. Compounded GLP-1 medication deserves that kind of continuity, and we would rather give you one accountable doctor than a queue of interchangeable ones.

If you are searching for medical weight loss in Kokomo, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

There is no New Hope Weight Loss office in Kokomo, and there does not need to be, since the same doctor-led program is delivered to every corner of Indiana through telehealth visits. We care for patients throughout downtown Kokomo and the greater Howard County area of north-central Indiana. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Kokomo you are.

A patient in the busiest part of Kokomo and one in a quiet Indiana suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. There is no distance surcharge for Kokomo, so you pay the same $119 review fee whether you live near the downtown Kokomo and the greater Howard County area of north-central Indiana area or anywhere else in Indiana. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Kokomo and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Kokomo

The path from curious to treated is short, and it all runs through your screen. People in Kokomo start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Kokomo home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Kokomo

Can people from Kokomo get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Kokomo, Indiana. Whether you are in downtown Kokomo and the greater Howard County area of north-central Indiana or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Kokomo patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Kokomo residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Kokomo inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Kokomo?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Kokomo.

What areas of Kokomo do you serve?

We serve patients from across Kokomo by telehealth, including downtown Kokomo and the greater Howard County area of north-central Indiana.

Who qualifies for the program in Kokomo?

Eligibility for Kokomo patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Kokomo Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kokomo, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.